Samuel D. Isaly just provided an update on activist position in Nivalis Therapeutics, Inc.

Samuel D. Isaly just filed a "Statement of acquisition of beneficial ownership", which is also known as a 13D. In the filing, it appears as though Samuel D. Isaly claims to own 3,298,516 shares. This represents 23.76% of Nivalis Therapeutics, Inc..

Please note that typos are common in SEC filings. Please verify the information reported above before acting on it.

To receive a free e-mail notification whenever Nivalis Therapeutics, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

Nivalis Therapeutics, Inc. Just Filed Its Quarterly Report: Net Loss Per ShareWe... - Aug. 9, 2018
Nivalis Therapeutics, Inc.'s See Remarks just declared ownership of no shares of Nivalis Therapeutics, Inc. - Aug. 8, 2018
Nivalis Therapeutics, Inc.'s See Remarks was just granted 150,000 options - Aug. 8, 2018
Nivalis Therapeutics: Alpine Immune Sciences Strengthens Leadership Team With Appointment Of Mark Litton As President And Chief Operating Officer - Aug. 6, 2018

Auto Refresh